Heart Pillow - Chemoteraphy
Hepi_Qt
1 other identifier
interventional
60
1 country
1
Brief Summary
Breast cancer is a health problem with increasing prevalence, along with more effective therapeutic responses and less mutilating surgeries. The process of caring for patients crosses different levels: the diagnostic phase, which is mostly outpatient, the surgical treatment phase, which is mostly short-term inpatient, and the medical treatment phase in a day hospital. An integrated and structured care model based on specialized nursing skills can help improve self-care, quality of life and well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2025
CompletedFirst Submitted
Initial submission to the registry
April 16, 2025
CompletedFirst Posted
Study publicly available on registry
May 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
May 22, 2025
May 1, 2025
1.8 years
April 16, 2025
May 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recovering mobility in the homolateral upper limb
The measures used are functional assessment of the upper limb with the Disabilities of the Arm, Shoulder and Hand (DASH-PT) scale: 30-item self-reported questionnaire in which the response options are presented as 5-point Likert scales. Scores range from 0 (no disability) to 100 (most severe disability). Assessment of muscle strength with dynamometry and assessment of amplitude by goniometry.
Every 3 weeks until the end of chemotherapy treatment. The result of the evaluation is translated into: Kgf (Muscle strength); Degrees (goniometry). Time Points: T0-first evaluation appointment (chemotherapy); T1 at Tx-evaluation every 3 weeks
Other Outcomes (2)
Upper limb lymphoedema
Every 3 weeks until the end of chemotherapy treatment. Time Points: T0-first evaluation appointment (chemotherapy); T1 at Tx-evaluation every 3 weeks
Sleep quality
At the start of chemotherapy after surgery, until the end of the treatment cycle (approximately 3 months). Time Points: T0-first evaluation appointment (chemotherapy); T1 at Tx-evaluation every 3 weeks
Study Arms (1)
Heart Pillow Group
EXPERIMENTALInterventions
Self-Care: Teach techniques to perform diminished or dependent self-care. Demonstrate assistive devices for self-care. Teach and train techniques and the use of assistive devices. Scare Tissue: Perform massage techniques on scar tissue: gliding and friction. Teach and train massage technique.
Eligibility Criteria
You may qualify if:
- Breast cancer patients undergoing chemotherapy after surgery.
You may not qualify if:
- Patients with breast cancer who did not undergo surgical treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- José Manuel Afonso Moreiralead
- Unidade Local de Saúde do Alentejo Centralcollaborator
- University of Évoracollaborator
Study Sites (1)
Évora
Evora, Portugal
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Isabel Bico, PhD
University of Évora
- STUDY CHAIR
Paula Sousa, MsC
ULSAC
- STUDY CHAIR
Sofia Braga, MsC
ULSAC
- STUDY CHAIR
Carmelinda Talhinhas
ULSAC
- STUDY CHAIR
José Moreira
University of Évora
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
April 16, 2025
First Posted
May 22, 2025
Study Start
March 1, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
May 22, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
Participants' personal data will not be shared, as recommended by the ethics committee. All data will be anonymized.